Changes of serum brain-derived neurotrophic factor in children with obstructive sleep apnoea-hypopnoea syndrome following adenotonsillectomy

Journal of International Medical Research

Volumn 38, Issue 6, 2010, Pages 1942-1951

  Wang, Y ^a   Wang, J J ^b   Zhao, M Q ^b   Liu, S M ^b   Li, Y Z ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Adenotonsillectomy; Brain derived neurotrophic factor; Obstructive sleep apnoea hypopnoea syndrome; Paediatric patients

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; SEROTONIN; TRANSFORMING GROWTH FACTOR BETA1;

ADENOTONSILLECTOMY; ARTICLE; BRAIN LEVEL; CHILD; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COGNITION; FEMALE; HUMAN; MALE; POLYSOMNOGRAPHY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRESCHOOL CHILD; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; REM SLEEP; SCORING SYSTEM; SLEEP APNEA SYNDROME; THROMBOCYTE COUNT;

EID: 78650831054     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001003800607     Document Type: Article

References (35)

1. Guilleminault C, Winkle R, Korobkin R, et al: Children and nocturnal snoring: evaluation of the effects of sleep related respiratory resistive load and daytime functioning. Eur J Pediatr 1982; 139: 165-171.
2. Rhodes SK, Shimoda KC, Waid LR: Neurocognitive deficits in morbidly obese children with sleep apnea. J Pediatr 1995; 127: 741-744.
3. Owens J, Spirito A, Marcotte A: Neuropsychological and behavioral correlates of obstructive sleep apnea syndrome in children: a preliminary study. Sleep Breath 2000; 4: 67-78.
4. Schlosshan D, Elliott MW: Sleep 3: Clinical presentation and diagnosis of the obstructive sleep apnoea hypopnoea syndrome. Thorax 2004; 59: 347-352.
5. Beebe DW, Gozal D: Obstructive sleep apnea and the prefrontal cortex: towards a comprehensive model linking nocturnal upper airway obstruction to daytime cognitive and behavioral deficits. J Sleep Res 2002; 11: 1-16.
6. Gozal D: Sleep disordered breathing and school performance in children. Pediatrics 1998; 102: 616-620.
7. Lommatzsch M, Zingler D, Schuhbaeck K, et al: The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol Aging 2005; 26: 115-123.
8. Karege F, Perret G, Bondolfi G, et al: Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 2002; 109: 143-148.
9. Karege F, Schwald M, Cisse M: Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci Lett 2002; 328: 261-264.
10. Pan W, Banks WA, Fasold MB, et al: Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 1998; 37: 1553-1561.
11. 2+ channels signalling. Eur J Neurosci 2002; 16: 2297-2310.
12. Sherwood NT, Lo DC: Long-term enhancement of central synaptic transmission by chronic brain-derived neurotrophic factor treatment. J Neurosci 1999; 19: 7025-7036.
13. Hartmann M, Heumann R, Lessmann V: Synaptic secretion of BDNF after high- frequency stimulation of glutamatergic synapses. EMBO J 2001; 20: 5887-5897.
14. Kafitz KW, Rose CR, Thoenen H, et al: Neurotrophin-evoked rapid excitation through TrkB receptors. Nature 1999; 401: 918-921.
15. Carter AR, Chen C, Schwartz PM, et al: Brain- derived neurotrophic factor modulates cerebellar plasticity and synaptic ultrastructure. J Neurosci 2002; 22: 1316-1327.
16. Kang H, Schuman EM: Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus. Science 1995; 267: 1658-1662.
17. Li YX, Zhang Y, Lester HA, et al: Enhancement of neurotransmitter release induced by brain- derived neurotrophic factor in cultured hippocampal neurons. J Neurosci 1998; 18: 10231-10240.
18. Winter J: Brain derived neurotrophic factor, but not nerve growth factor, regulates capsaicin sensitivity of rat vagal ganglion neurones. Neurosci Lett 1998; 241: 21-24.
19. Egan MF, Kojima M, Callicott JH, et al: The BDNF valumet polymorphism affects activity- dependent secretion of BDNF and human memory and hippocampal function. Cell 2003; 112: 257-269.
20. Hall J, Thomas KL, Everitt BJ: Rapid and selective induction of BDNF expression in the hippocampus during contextual learning. Nat Neurosci 2000; 3: 533-535.
21. Yamada K, Mizuno M, Nabeshima T: Role for brain-derived neurotrophic factor in learning and memory. Life Sci 2002; 70: 735-744.
22. Chen B, Dowlatshahi D, MacQueen GM, et al: Increased hippocampal BDNF immuno- reactivity in subjects treated with anti- depressant medication. Biol Psychiatry 2001; 50 260-265.
23. Sohrabji F, Lewis DK: Implications for neurodegenerative diseases. Front Neuroendocrinol 2006; 27: 404-414.
24. Licastro F, Chiappelli M, Ruscica M, et al: Altered cytokine and acute phase response protein levels in the blood of children with Down's syndrome: relationship with dementia of Alzheimer's type. Int J Immunopathol Pharmacol 2005; 18: 165-172.
25. Rosenfeld RD, Zeni L, Haniu M, et al: Purification and identification of brain-derived neurotrophic factor from human serum. Protein Expr Purif 1995; 6: 465-471.
26. Fujimura H, Altar CA, Chen R, et al: Brain derived neurotrophic factor is stored in human platelets and released by agonist stimulation. Thromb Haemost 2002; 87: 728-734.
27. Radka SF, Holst PA, Fritsche M, et al: Presence of brain-derived neurotrophic factor in brain and human and rat but not mouse serum detected by a sensitive and specific immunoassay. Brain Res 1996; 709: 122-130.
28. Hairston IS, Peyron C, Denning DP, et al: Sleep deprivation effects on growth factor expression in neonatal rats: a potential role for BDNF in the mediation of delta power. J Neurophysiol 2004; 91: 1586-1595.
29. Pliego-Rivero FB, Bayatti N, Giannakoulopoulos X, et al: Brain-derived neurotrophic factor in human platelets. Biochem Pharmacol 1997; 54: 207-209.
30. Staats R, Stoll P, Zingler D, et al: Regulation of brain-derived neurotrophic factor (BDNF) during sleep apnoea treatment. Thorax 2005; 60: 688-692.
31. John MW: A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991; 14: 540-545.
32. Raven JC, Court JH, Raven J: Manual for Raven's Standard Progressive Matrices and Vocabulary Scales. San Antonio: The Psychological Corporation, 1996; pp 50-66.
33. Friedman BC, Amitai AH, Kozminsky E, et al: Adenotonsillectomy improves neurocognitive function in children with obstructive sleep apnea syndrome. Sleep 2003; 26: 999-1005.
34. Ali NJ, Pitson D, Stradling JR: Sleep disordered breathing: effects of adenotonsillectomy on behavior and psychological functioning. Eur J Pediatr 1996; 15: 56-62.
35. Lewin DS, Rosen RC, England SJ, et al: Preliminary evidence of behavioral and cognitive sequelae of obstructive sleep apnea in children. Sleep Med 2002; 3: 5-13